Based on SEC filing data. A biotech corporation founded in 2019 and based in Sydney raised $5.0M in a Series A convertible note round. The company operates in the biotech sector.
Get notified the moment AdvanCell Isotopes Pty Ltd files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.